Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14461)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 14, 2022 (publication date) through May 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yasmin F, Najeeb H, Shaikh S, Hasanain M, Naeem U, Moeed A, Koritala T, Hasan S, Surani S. Novel drug delivery systems for inflammatory bowel disease. World J Gastroenterol 2022; 28(18): 1922-1933 [PMID: 35664964 DOI: 10.3748/wjg.v28.i18.1922] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i18/1922.htm |
| Number | Citing Articles |
| 1 |
Dan Yang, Huanxuan Zeng, Yuan Zhuang, Shicui Jiang, Wenjie Pan. Nanodrug delivery materials for digestive system diseases. APL Materials 2024; 12(6) doi: 10.1063/5.0214020
|
| 2 |
Zhaowei Luo, Zhanghua Qi, Jie Luo, Tingtao Chen. Potential applications of engineered bacteria in disease diagnosis and treatment. Microbiome Research Reports 2024; 4(1) doi: 10.20517/mrr.2024.57
|
| 3 |
Himanshu Solanki, Manashri Gondhalekar, Bhupendra Prajapati. Nanocarriers Based Colon Targeting. 2025; : 339 doi: 10.1016/B978-0-443-24806-1.00014-5
|
| 4 |
Seyed Yaser Vafaei, Amir Hossein Abdolghaffari, Reza Mahjub, Seyyed Majid Eslami, Motahareh Esmaeili, Mohammad Abdollahi, Fatemeh Atyabi, Rassoul Dinarvand, Abdul Ahad. Budesonide‐Loaded Hyaluronic Acid Nanoparticles for Targeted Delivery to the Inflamed Intestinal Mucosa in a Rodent Model of Colitis. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/7776092
|
| 5 |
Bo Wang, Jiquan Shen, Xinggao Wang, Ruixing Hou. Biomimetic nanoparticles for effective Celastrol delivery to targeted treatment of rheumatoid arthritis through the ROS-NF-κB inflammasome axis. International Immunopharmacology 2024; 131: 111822 doi: 10.1016/j.intimp.2024.111822
|
| 6 |
Angsagan Abdigazy, Mohammed Arfan, June Shao, Mohammad Shafiqul Islam, Md Farhad Hassan, Yasser Khan. 3D gas mapping in the gut with AI-enabled ingestible and wearable electronics. Cell Reports Physical Science 2024; 5(7): 101990 doi: 10.1016/j.xcrp.2024.101990
|
| 7 |
Haisheng Peng, Jiahe Wang, Jiayu Chen, Yanbo Peng, Xiaoxian Wang, Ying Chen, David L. Kaplan, Qun Wang. Challenges and opportunities in delivering oral peptides and proteins. Expert Opinion on Drug Delivery 2023; 20(10): 1349 doi: 10.1080/17425247.2023.2237408
|
| 8 |
Mohd Imran, Ahmad Zuhairi Abdullah, Fazlurrahman Khan, Young-Mog Kim, Omer Y. Bakather, Abdullah Ali Alamri, Syed Kashif Ali, Nujud Maslamani, Mohammad Ehtisham Khan, Muhammad Shahid Rashid, Mohamed Hassan. Harnessing the power of ternary nanocomposites: Iron oxide, multiwalled carbon nanotubes, and bentonite for superior ciprofloxacin adsorption. Inorganic Chemistry Communications 2024; 170: 113256 doi: 10.1016/j.inoche.2024.113256
|
| 9 |
Katharina Tatjana Kopp, Lien Saerens, Jody Voorspoels, Guy Van den Mooter. Solidification and oral delivery of biologics to the colon- A review. European Journal of Pharmaceutical Sciences 2023; 190: 106523 doi: 10.1016/j.ejps.2023.106523
|
| 10 |
Ying Zhou, Chunmei Li, Mingming Chen, Congying Gao, Chi Lin, Chang Wu Yu, Ning Wang. Impact of continuous care on quality life of patients with inflammatory bowel disease based on multi-disciplinary cooperation on WeChat platform. Technology and Health Care 2024; 32(6): 4909 doi: 10.3233/THC-232032
|
| 11 |
Zihui Zhang, Peng Wang, Hengdeng Liu, Hanwen Wang, Miao Zhen, Xuefeng He, Suyue Gao, Juntao Xie, Julin Xie. Paquinimod‐hydrogel hybrid microneedle array patch alleviates hypertrophic scar via inhibiting M1 polarization. Bioengineering & Translational Medicine 2025; doi: 10.1002/btm2.70016
|
| 12 |
Chunhua Yang, Kripa Sharma, Rabeya Jafrin Mow, Eunice Bolay, Anand Srinivasan, Didier Merlin. Unleashing the Potential of Oral Deliverable Nanomedicine in the Treatment of Inflammatory Bowel Disease. Cellular and Molecular Gastroenterology and Hepatology 2024; 18(2): 101333 doi: 10.1016/j.jcmgh.2024.03.005
|
| 13 |
Changshun Zhao, Suchen Wen, Rui Xu, Ke Wang, Yinan Zhong, Dechun Huang, Bingbing Zhao, Wei Chen. Oral delivery of ultra-small zwitterionic nanoparticles to overcome mucus and epithelial barriers for macrophage modulation and colitis therapy. Acta Biomaterialia 2025; 196: 399 doi: 10.1016/j.actbio.2025.02.039
|
| 14 |
Anupam Sarma, Tapash Chakraborty, Bhrigu Kumar Das, Ashis Kumar Goswami. Nanocarriers Based Colon Targeting. 2025; : 601 doi: 10.1016/B978-0-443-24806-1.00022-4
|
| 15 |
Haiming Chen, Waliul Islam, Jessica El Halabi, Ling Li, Florin M. Selaru. Innovative Gastrointestinal Drug Delivery Systems: Nanoparticles, Hydrogels, and Microgrippers. Frontiers in Bioscience-Landmark 2025; 30(2) doi: 10.31083/FBL25281
|
| 16 |
Chinmaya Mahapatra. Nanomedicine in Translational Research. 2025; : 229 doi: 10.1016/B978-0-443-22257-3.00011-8
|
| 17 |
Anas Ahmad, Mohammad Imran. Emergence of Sustainable Biomaterials in Tackling Inflammatory Diseases. Smart Nanomaterials Technology 2025; : 25 doi: 10.1007/978-981-96-2112-5_2
|
| 18 |
Chin-Hsiao Tseng. Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients. Pharmaceuticals 2023; 16(5): 679 doi: 10.3390/ph16050679
|
| 19 |
Christina Kratschmer, David T. Curiel, Matthew A. Ciorba. Gut-directed therapeutics in inflammatory bowel disease. Current Opinion in Gastroenterology 2025; doi: 10.1097/MOG.0000000000001099
|
| 20 |
Shaymaa S. Seoudi, Eman A. Allam, Amal H. El-Kamel, Hagar Elkafrawy, Riham M. El-Moslemany. Targeted delivery of budesonide in acetic acid induced colitis: impact on miR-21 and E-cadherin expression. Drug Delivery and Translational Research 2023; 13(11): 2930 doi: 10.1007/s13346-023-01363-2
|
| 21 |
Jagtar Singh, Mohit Sharma, Harmeet Singh, Pinky Arora, Puneet Utreja, Shubham Kumar. Formulation, Characterization and In Vitro Evaluation of Mesalamine and Bifidobacterium bifidum Loaded Hydrogel Beads in Capsule System for Colon Targeted Delivery. AAPS PharmSciTech 2024; 25(3) doi: 10.1208/s12249-024-02764-3
|
| 22 |
Dinesh Kumar, Komal Sachdeva, Rajni Tanwar, Sunita Devi. Review on novel targeted enzyme drug delivery systems: enzymosomes. Soft Matter 2024; 20(23): 4524 doi: 10.1039/D4SM00301B
|
| 23 |
Yinfeng Zhang, Tingting Wang, Meng Sun, Yueyue Song, Xinyuan Huang, Shutian Zhang, Jun Yang, Jinfeng Zhang. Advanced Nanomedicine: Redefining Therapeutic Paradigms for Inflammatory Bowel Disease. Advanced Healthcare Materials 2023; 12(19) doi: 10.1002/adhm.202300069
|
| 24 |
Shilin Zhou, Zhenxin Yu, Wenqing Yao, Mengdi Wang, Yongqiang Yang, Jien Qin, Xiaochen Wu, Chuanlong Guo. Pectin/caffeic acid nanoparticles in a poloxamer thermosensitive gel for the treatment of ulcerative colitis by inhibiting cGAS-STING pathway. Colloids and Surfaces B: Biointerfaces 2025; 247: 114419 doi: 10.1016/j.colsurfb.2024.114419
|
| 25 |
Ranjit K. Harwansh, Hemant Bhati, Rohitas Deshmukh. Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel
Delivery Systems of Chlorogenic Acid for the Management of Diseases with a
Special Emphasis on Ulcerative Colitis. Current Pharmaceutical Design 2024; 30(6): 420 doi: 10.2174/0113816128295753240129074035
|
| 26 |
Ahmad Darvishi, Mojtaba Ansari. Thermoresponsive and Supramolecular Polymers: Interesting Biomaterials for Drug Delivery. Biotechnology Journal 2024; 19(10) doi: 10.1002/biot.202400379
|
| 27 |
Raj Kumar, Tamanna Islam, Md Nurunnabi. Mucoadhesive carriers for oral drug delivery. Journal of Controlled Release 2022; 351: 504 doi: 10.1016/j.jconrel.2022.09.024
|
| 28 |
Siyu Zhu, Zhenlin Yang, Yulong Liu, Lan Cheng, Dingpei Long, Fangyin Dai. Oral Lipid Nanoparticles for Improving the Efficiency of Drug Delivery Systems in Ulcerative Colitis: Recent Advances and Future Prospects. Pharmaceutics 2025; 17(5): 547 doi: 10.3390/pharmaceutics17050547
|
| 29 |
Dongdong Liu, Meng Wei, Wenrui Yan, Hua Xie, Yingbao Sun, Bochuan Yuan, Yiguang Jin. Potential applications of drug delivery technologies against radiation enteritis. Expert Opinion on Drug Delivery 2023; 20(4): 435 doi: 10.1080/17425247.2023.2183948
|
| 30 |
Elena Gardey, Johannes C. Brendel, Andreas Stallmach. Pathophysiology of IBD as a Key Strategy for Polymeric Nanoparticle Development. Advanced Therapeutics 2025; 8(3) doi: 10.1002/adtp.202400439
|
| 31 |
You Chen, Juewen Feng, Yang Chen, Chuanhe Xia, Min Yao, Wenxing Ding, Xiang Li, Xiuzhi Fu, Shulei Zheng, Yin Ma, Jiafeng Zou, Minbo Lan, Feng Gao. ROS-responsive nano-medicine for navigating autophagy to enhance targeted therapy of inflammatory bowel disease. International Journal of Pharmaceutics 2024; 659: 124117 doi: 10.1016/j.ijpharm.2024.124117
|
| 32 |
Kat F. Kiilerich, Trine Andresen, Behrooz Darbani, Laura H. K. Gregersen, Anette Liljensøe, Tue B. Bennike, René Holm, Jesper B. Moeller, Vibeke Andersen. Advancing Inflammatory Bowel Disease Treatment by Targeting the Innate Immune System and Precision Drug Delivery. International Journal of Molecular Sciences 2025; 26(2): 575 doi: 10.3390/ijms26020575
|
| 33 |
Luming Deng, Zhenhui Feng, Xingyan Li, Lvhua Fan, Xia Wu, Samad Tavakoli, Yuzhen Zhu, Hua Ye, Kefeng Wu. Exploring the potential mechanism of B-phycoerythrin on DSS-induced colitis and colitis-associated bone loss based on network pharmacology, molecular docking, and experimental validation. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-90011-5
|
| 34 |
Sem Geertsema, Arno R. Bourgonje, Raphael R. Fagundes, Ranko Gacesa, Rinse K. Weersma, Harry van Goor, Giovanni E. Mann, Gerard Dijkstra, Klaas N. Faber. The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease. Trends in Molecular Medicine 2023; 29(10): 830 doi: 10.1016/j.molmed.2023.07.008
|
| 35 |
Xueyong Xie, Yaohui Wang, Bo Deng, Michael R Blatchley, Dongwei Lan, Yizhou Xie, Meng Lei, Na Liu, Feng Xu, Zhao Wei. Matrix metalloproteinase-responsive hydrogels with tunable retention for on-demand therapy of inflammatory bowel disease. Acta Biomaterialia 2024; 186: 354 doi: 10.1016/j.actbio.2024.07.054
|
| 36 |
Enhui Tang, Huan Lin, Yihao Yang, Jiawen Xu, Baiwen Lin, Yang Yang, Zijian Huang, Xinlan Wu. Dietary astragalin confers protection against lipopolysaccharide-induced intestinal mucosal barrier damage through mitigating inflammation and modulating intestinal microbiota. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1481203
|
| 37 |
Fatemeh Soltani, Hossein Kamali, Abbas Akhgari, Mahboobeh Ghasemzadeh Rahbardar, Hadi Afrasiabi Garekani, Ali Nokhodchi, Fatemeh Sadeghi. Combination of time-dependent polymer and inulin as a coating for sustained delivery of budesonide pellets aimed for use in IBD treatment. Journal of Drug Delivery Science and Technology 2023; 88: 104927 doi: 10.1016/j.jddst.2023.104927
|
| 38 |
Parisa Hashemi, Shirin Mahmoodi, Abdolmajid Ghasemian. An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases. Archives of Microbiology 2023; 205(8) doi: 10.1007/s00203-023-03629-2
|
| 39 |
Siyao Gu, Xiaona Zhao, Fang Wan, Dayong Gu, Weidong Xie, Cheng Gao. Intracellularly Gelated Macrophages Loaded with Probiotics for Therapy of Colitis. Nano Letters 2024; 24(43): 13504 doi: 10.1021/acs.nanolett.4c02699
|
| 40 |
Chinasa Valerie Olovo, Dickson Kofi Wiredu Ocansey, Ying Ji, Xinxiang Huang, Min Xu. Bacterial membrane vesicles in the pathogenesis and treatment of inflammatory bowel disease. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2341670
|
| 41 |
Yijun Wu, Jinfeng Song, Xiaochen Wang, Longxia Li, Jie Chang, Yunfeng Ma. pH and redox dual response nano-suppository for the treatment of ulcerative colitis. Drug Delivery and Translational Research 2024; 14(7): 1954 doi: 10.1007/s13346-023-01499-1
|
| 42 |
Salvatore Rizzo, Elide Zingale, Alessia Romeo, Rosamaria Lombardo, Rosario Pignatello. Colon Delivery of Nutraceutical Ingredients by Food-Grade Polymeric Systems: An Overview of Technological Characterization and Biological Evaluation. Applied Sciences 2023; 13(9): 5443 doi: 10.3390/app13095443
|
| 43 |
Enhui Tang, Tong Hu, Zhaokang Jiang, Xiaojun Shen, Huan Lin, Haiyan Xian, Xinlan Wu. Isoquercitrin alleviates lipopolysaccharide-induced intestinal mucosal barrier damage in mice by regulating TLR4/MyD88/NF-κB signaling pathway and intestinal flora. Food & Function 2024; 15(1): 295 doi: 10.1039/D3FO03319H
|
| 44 |
Sabuj Kumar Saha, A.H.M. Nazmul Hasan, Ramisa Anjum, Shariun Nahar Rimun, Nujhat Zayma Rahman, Md. Khokon Miah Akanda, Mohiuddin Ahmed Buhiyan, SM Ashraful Islam. From Prodrug to Multimatrix: Recent Advancement of Colon Specific Drug Delivery System. Sciences of Pharmacy 2024; 3(3): 120 doi: 10.58920/sciphar0303233
|
| 45 |
Dinakar Swastha, Nambolan Varsha, Suresh Aravind, Kavassery Balasubramanian Samyuktha, Muruganandam Mohaneswari Yokesh, Akshad Balde, Bakthavatchalam Loganathan Ayilya, Soottawat Benjakul, Se-Kwon Kim, Rasool Abdul Nazeer. Alginate-based drug carrier systems to target inflammatory bowel disease: A review. International Journal of Biological Macromolecules 2023; 244: 125472 doi: 10.1016/j.ijbiomac.2023.125472
|
| 46 |
Mahdi Rahimi, Zahra Kariminezhad, Elsa-Patricia Rondon, Hassan Fahmi, Julio C. Fernandes, Mohamed Benderdour. Chitosan nanovectors for siRNA delivery: New horizons for nonviral gene therapy. Carbohydrate Polymers 2025; 360: 123581 doi: 10.1016/j.carbpol.2025.123581
|
| 47 |
Hee-Jun Kim, Bohye Kim, Mi-Ra Lee, Moonjin Ra, Yongjun Lee. Bamboo Shoot and Artemisia capillaris Extract Mixture Ameliorates Dextran Sodium Sulfate-Induced Colitis. Current Issues in Molecular Biology 2022; 44(10): 5086 doi: 10.3390/cimb44100345
|
| 48 |
Ahmed Aljabri, Ghareb M. Soliman, Yasmin N. Ramadan, Mohammed A. Medhat, Helal F. Hetta. Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01558-6
|
| 49 |
Chia Wen Qi, Ummu Umaimah Mohd Nordin, Syed Mahmood, Nisha Rata Karusan, Ramsha Khalid, Nurdiana Nordin, Cristina Fornaguera, Noraini Ahmad. Gout Management Using Nanocarrier Systems: A Review. ACS Applied Nano Materials 2024; 7(9): 9816 doi: 10.1021/acsanm.3c06079
|
| 50 |
Shan Li, Tianyu Wu, Jingfeng Wu, Wensheng Chen, Dinglin Zhang. Recognizing the biological barriers and pathophysiological characteristics of the gastrointestinal tract for the design and application of nanotherapeutics. Drug Delivery 2024; 31(1) doi: 10.1080/10717544.2024.2415580
|
| 51 |
Jia Wang, Yuying Shi, Bei Mao, Biheng Zhang, Jie Yang, Zhijian Hu, Weifang Liao. Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids. Applied Materials Today 2024; 36: 102078 doi: 10.1016/j.apmt.2024.102078
|
| 52 |
Jingyuan Wu, Wanlin Ye, Jie Yu, Tuoyu Zhou, Nuo Zhou, Dennis K.P. Ng, Zhaoting Li. Engineered bacteria and bacterial derivatives as advanced therapeutics for inflammatory bowel disease. Essays in Biochemistry 2025; 69(02) doi: 10.1042/EBC20253003
|